# Clinical trials recruiting in New Mexico: 388 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 388 trials recruiting or not yet recruiting with a site in New Mexico, as read on November 19, 2026.

## The full list

Clinical trials recruiting in New Mexico: 388 rows for $19.40, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/new-mexico

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 388
- Recruiting or not yet: 388
- Read on: November 19, 2026

## Trials

The 25 newest of 388, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| October 29, 2026 | NCT07904078 | Demographic Data Collection in Healthcare | Pacific Institute for Research and Evaluation | Not applicable | Recruiting | Implementation Strategies | 1,320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904078) |
| October 19, 2026 | NCT07881432 | A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity | 2,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881432) |
| October 9, 2026 | NCT07868939 | Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) | Viking Therapeutics, Inc. | Phase 3 | Recruiting | Weight Loss | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868939) |
| September 30, 2026 | NCT07850063 | ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and... | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850063) |
| September 25, 2026 | NCT07842367 | Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study | University of Arkansas, Fayetteville | Phase 2 | Recruiting | Decision-Making, Patient Care, Treatment Decisions | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842367) |
| September 14, 2026 | NCT07817251 | Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema | Novo Nordisk A/S | Phase 3 | Recruiting | Diabetes Mellitus, Type 2 | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817251) |
| September 4, 2026 | NCT07805707 | A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Influenza, Human | 54,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805707) |
| September 4, 2026 | NCT07804615 | A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently... | Vima Therapeutics | Phase 2 | Recruiting | PARKINSON DISEASE (Disorder) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804615) |
| August 31, 2026 | NCT07795164 | Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH | Altimmune, Inc. | Phase 3 | Recruiting | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795164) |
| August 26, 2026 | NCT07787572 | Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing | The Mind Research Network | Not applicable | Not yet recruiting | Cannabis Use Disorder | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787572) |
| August 24, 2026 | NCT07782996 | A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST... | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782996) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 10, 2026 | NCT07754461 | A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Boehringer Ingelheim | Phase 3 | Recruiting | Type 2 Diabetes | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754461) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| July 29, 2026 | NCT07734649 | Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older | Sanofi | Phase 1/2 | Recruiting | Respiratory Syncytial Virus Immunization, Human Metapneumovirus Immunization, Healthy Volunteers | 2,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734649) |
| July 17, 2026 | NCT07711795 | Mindfulness Texting for Medication Adherence and Chronic Pain Management | University of New Mexico | Not applicable | Recruiting | Opioid Use Disorder (OUD), Chronic Pain | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711795) |
| July 17, 2026 | NCT07711002 | Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy... | AstraZeneca | Phase 3 | Recruiting | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | 1,330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711002) |
| June 29, 2026 | NCT07674654 | A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | TriGemX Bio, Inc. | Phase 3 | Recruiting | Acute Migraine | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07674654) |
| June 25, 2026 | NCT07667803 | A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM | AstraZeneca | Phase 3 | Recruiting | Weight Management | 4,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667803) |
| June 23, 2026 | NCT07662213 | A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662213) |
| June 23, 2026 | NCT07662135 | A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662135) |
| June 23, 2026 | NCT07662109 | A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662109) |
| June 22, 2026 | NCT07661056 | Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease | Biohaven Therapeutics Ltd. | Phase 3 | Recruiting | Graves Disease | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661056) |
| June 16, 2026 | NCT07650916 | A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With... | ViiV Healthcare | Phase 3 | Recruiting | HIV | 564 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650916) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of New Mexico Cancer Center | Albuquerque | 90 |
| University of New Mexico | Albuquerque | 38 |
| Presbyterian Kaseman Hospital | Albuquerque | 21 |
| University of New Mexico Comprehensive Cancer Center | Albuquerque | 20 |
| Presbyterian Rust Medical Center/Jorgensen Cancer Center | Rio Rancho | 16 |
| University of New Mexico Health Sciences Center | Albuquerque | 13 |
| Presbyterian Hospital | Albuquerque | 12 |
| Lovelace Medical Center-Saint Joseph Square | Albuquerque | 9 |
| University of New Mexico Hospital | Albuquerque | 9 |
| New Mexico Oncology Hematology Consultants | Albuquerque | 9 |
| Memorial Medical Center-Las Cruces | Las Cruces | 9 |
| Lovelace Women's Hospital | Albuquerque | 8 |
| Christus St. Vincent Regional Cancer Center | Santa Fe | 6 |
| The Mind Research Network | Albuquerque | 6 |
| New Mexico VA Health Care System, Albuquerque, NM | Albuquerque | 5 |
| San Juan Oncology Associates | Farmington | 5 |
| University of New Mexico Health Science Center | Albuquerque | 5 |
| Albuquerque Clinical Trials, Inc. | Albuquerque | 5 |
| New Mexico Oncology Hematology Consultants Ltd. | Albuquerque | 3 |
| Renal Medicine Associates | Albuquerque | 3 |
| Inspire Santa Fe Medical Group | Santa Fe | 3 |
| Albuquerque Clinical Trials | Albuquerque | 3 |
| CHRISTUS St. Vincent Regional Cancer Center | Santa Fe | 3 |
| IMA Clinical Research Albuquerque | Albuquerque | 2 |
| Presbyterian Rust Jorgensen Cancer | Rio Rancho | 2 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 7 |
| Phase 1/2 | 10 |
| Phase 2 | 73 |
| Phase 2/3 | 16 |
| Phase 3 | 167 |
| Phase 4 | 10 |
| Not applicable | 56 |
| Observational | 48 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Breast Neoplasms | 21 |
| Neoplasms | 18 |
| Lung Neoplasms | 15 |
| Endometrial Neoplasms | 14 |
| Neoplasm Metastasis | 13 |
| Ovarian Neoplasms | 12 |
| Cardiovascular Diseases | 11 |
| Diabetes Mellitus, Type 2 | 11 |
| Melanoma | 11 |
| Prostatic Neoplasms | 11 |
| Leukemia, Myeloid, Acute | 10 |
| Obesity | 10 |
| Colorectal Neoplasms | 8 |
| Renal Insufficiency, Chronic | 8 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Colonic Neoplasms | 7 |
| Pancreatic Neoplasms | 7 |
| Multiple Myeloma | 7 |
| Carcinoma | 6 |
| Diabetes Mellitus | 6 |
| Esophageal Neoplasms | 6 |
| Heart Failure | 6 |
| Carcinoma, Renal Cell | 5 |
| Hypertension | 5 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 31 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 25 |
| University of New Mexico | 24 |
| NRG Oncology | 14 |
| Children's Oncology Group | 14 |
| SWOG Cancer Research Network | 11 |
| Alliance for Clinical Trials in Oncology | 11 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 10 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 10 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 8 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 7 |
| ECOG-ACRIN Cancer Research Group | 6 |
| VA Office of Research and Development | 5 |
| NICHD Neonatal Research Network | 5 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 5 |
| The Mind Research Network | 5 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 4 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 4 |
| New Mexico Cancer Research Alliance | 4 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 4 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 4 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 4 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 3 |
| [Gilead Sciences](https://specstream.ai/data/clinical-trials/company/gilead-sciences) | 3 |
| Duke University | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New Mexico

- [Masonry and concrete contractors in New Mexico, United States](https://specstream.ai/data/businesses/masonry-and-concrete-contractors/new-mexico-united-states)
- [Landscaping companies in New Mexico, United States](https://specstream.ai/data/businesses/landscaping-companies/new-mexico-united-states)
- [Investment management firms in New Mexico, United States](https://specstream.ai/data/businesses/investment-management-firms/new-mexico-united-states)
- [Hospices in New Mexico, United States](https://specstream.ai/data/businesses/hospices/new-mexico-united-states)
- [Garage door companies in New Mexico, United States](https://specstream.ai/data/businesses/garage-door-companies/new-mexico-united-states)
- [Excavation contractors in New Mexico, United States](https://specstream.ai/data/businesses/excavation-contractors/new-mexico-united-states)
